Cargando…
Case report: Oral anticoagulant combined with percutaneous coronary intervention for peripheral embolization of left ventricular thrombus caused by myocardial infarction in a patient with diabetes mellitus
BACKGROUND: Left ventricular thrombus (LVT) is a well-recognized complication of myocardial infarction (MI) in patients with diabetes. An embolic complication caused by LVT is a key clinical problem and is associated with worsened long-term survival. CASE PRESENTATION: A 45-year-old man with persist...
Autores principales: | Zhu, Chao, Zhou, Li, Gao, Hongli, Wang, Jiali, Li, Jiayu, Chen, Hui, Li, Hongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775277/ https://www.ncbi.nlm.nih.gov/pubmed/36568554 http://dx.doi.org/10.3389/fcvm.2022.1019945 |
Ejemplares similares
-
Acute Myocardial Infarction From Embolized Left Ventricular Thrombus in Coronavirus Disease 2019
por: Samuel, Anna R.
Publicado: (2022) -
Treatment of left ventricular thrombus after myocardial infarction: need longer or lifetime use of anticoagulants?
por: Du, Chong, et al.
Publicado: (2021) -
Direct Oral Anticoagulants for Stroke and Systemic Embolism Prevention in Patients with Left Ventricular Thrombus
por: Badescu, Minerva Codruta, et al.
Publicado: (2023) -
Risk factors for in-hospital systemic thromboembolism in myocardial infarction patients with left-ventricular thrombus: A multicenter retrospective study
por: Zhou, Wei, et al.
Publicado: (2022) -
Fatal cerebral haemorrhagic infarction due to left ventricular thrombus after healing of immune checkpoint inhibitor-associated myocarditis
por: Sakai, Shunsuke, et al.
Publicado: (2020)